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Abstract 
Prion diseases are associated with the misfolding of the normal helical cellular form of prion 
protein (PrPC) into the beta-sheet-rich scrapie form (PrPSc) and the subsequent aggregation of 
PrPSc into amyloid fibrils. Recent studies demonstrated that a naturally occurring variant V127 
of human PrPC is intrinsically resistant to prion conversion and aggregation, and can 
completely prevent prion diseases. However, the underlying molecular mechanism remains 
elusive. Herein we perform multiple microsecond molecular dynamics simulations on both 
wildtype (WT) and V127 variant of human PrPC to understand at atomic level the protective 
effect of V127 variant. Our simulations show that G127V mutation not only increases the 
rigidity of the S2-H2 loop between strand-2 (S2) and helix-2 (H2), but also allosterically 
enhances the stability of  the H2 C-terminal region. Interestingly, previous studies reported that 
animals with rigid S2-H2 loop usually do not develop prion diseases, and the increase in H2 
C-terminal stability can prevent misfolding and oligomerization of prion protein. The allosteric 
paths from G/V127 to H2 C-terminal region are identified using dynamical network analyses. 
Moreover, community network analyses illustrate that G127V mutation enhances the global 
correlations and intra-molecular interactions of PrP, thus stabilizing the overall PrPC structure 
and inhibiting its conversion into PrPSc. This study provides mechanistic understanding of 
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human V127 variant in preventing prion conversion which may be helpful for the rational 
design of potent anti-prion compounds. 
 
Introduction 
The transmissible spongiform encephalopathies (TSEs), or prion diseases, are a group of fatal 
neurodegenerative disorders including scrapie in sheep,[1,2] chronic wasting disease in deer,[3] 
spongiform encephalopathy in bovine,[4] Creutzfeldt-Jakob disease (CJD),[5,6] fatal familial 
insomnia (FII),[7,8] and kuru[9,10] in human. The “prion hypothesis”, in other words, the TSEs 
are caused by the misfolding and aggregation of prion proteins (PrP), has dominated the field 
since 1982.[11–16] This hypothesis has also been extended to cover other neurodegenerations 
such as Alzheimer’s disease, Amyotrophic Lateral Sclerosis (ALS), and Parkinson’s disease, 
which are respectively associated with the aggregation of beta amyloids, TDP-43, and α-
synucleins.[17–23] 
 
The key hallmark underlying the pathological misfolding and aggregation of PrPs is the 
conformational transition from a helix-rich conformer (PrPC, in which C stands for cellular) to 
a sheet-rich pathogenic (or scrapie-like) conformation (PrPSc).[24–26] The PrPC exists as a 
glycoprotein composed of 209 residues including a highly disordered N-terminal segment and 
a globular folded region comprising residues 125~231. NMR[27–29] and X-ray[30] studies have 
shown that the folded domain of human PrPC contains three α-helices (residues 144-154, 173-
194, and 200-228, denoted respectively H1, H2, and H3) and two short antiparallel β-strands 
(residues 128-131, and 161-164, denoted respectively S1 and S2) (Fig. 1a). Although numerous 
works have suggested that PrPC is related to a wide range of different cellular processes,[31–36] 
its biological function remains largely unknown. On the other hand, the PrPSc isoform has 
characteristics of enriched β-sheet structures, proteases-resistance and a high propensity to 
aggregate into amyloid fibrils.[37–39] However, solving the atomic-level structure of PrPSc is 
very challenging, possibly due to its insolubility, short survival time, and its fast aggregation 
into toxic fibrils.[40–42] 
 
About 10% to 15% of human prion diseases are caused by mutations of the PrP.[43] These 
mutations lead to the spontaneous misfolding of the protein and the formation of neurotoxic 
protofibrils and fibrils. Examples of the more than twenty reported disease-related mutations 
include D178N,[44,45] Q217R,[46] and T188R,[47] related respectively to FFI, Gerstmann–
Sträussler–Scheinker syndrome (GSS), and CJD. On the contrary, a few mutations (M129V 
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polymorphism,[48] E219K polymorphism,[49,50] E200K,[51] and G127V) are reported to have 
protective effect on prion diseases. For example, Mead and coworkers reported a novel 
acquired prion disease resistance factor (G127V mutation) selected during the kuru epidemic 
in Papua New Guinea.[52] Asante et al. further performed transgenic mice experiments and 
showed that the V127 variant completely prevents prion diseases and that its mechanism is 
distinct from the M129V polymorphism.[53] In addition, Sabareesan and Udgaonkar showed 
that the G126V mutation in mouse PrP (equivalent to G127V in human PrP) can slow the initial 
fibril growth by extending the lag phase.[54] In spite of these experimental advances, the 
molecular mechanisms underlying the complete resistance of the V127 variant to prion disease 
remain mostly unknown. 
 
Molecular dynamics (MD) simulations have been widely used to investigate the structural and 
dynamical properties of proteins.[55–57] In 2016, Yao et.al. reported the first computational study 
on PrP dimer and its V127 variant. Their 100-ns simulations showed that the constructed PrP 
dimer with G127V mutation is less stable than the WT dimer.[58] Recently, Lin et.al solved the 
NMR structures of monomeric WT PrP and the G127V mutant and found G127V to be less 
stable than WT. They also performed 100-ns MD simulations starting from their NMR 
structures and showed that S1 and S2 in G127V is less populated than those in WT.[59] However, 
due to the short time scales of their simulations, the atomic-level mechanism underlying the 
G127V-mutation-induced protective effect of PrP is not well understood. Herein, we have 
carried out six independent 2-μs all-atom MD simulations on WT PrP monomer and its V127 
variant. Our simulations show that the G127V mutation stabilizes the PrP monomeric structure 
by greatly enhancing the structural rigidity of the S2-H2 loop and the stability of the C-terminal 
of H2. The increased rigidity of S2-H2 loop and the enhanced H2 stability in V127 variant may 
inhibit the structural conversion from human PrPC to PrPSc, thus prevent prion disease. Our 
hypothesis is supported by the fact that prions are poorly transmissible to animals with their 
PrPC carrying a rigid loop and a recent finding showing that stabilization of H2 of prion protein 
prevents its misfolding and oligomerization. Interaction analysis and optimal allosteric path 
analysis provide the atomic-level mechanism of G127V in the enhancement of S2-H2 loop 
rigidity and the H2 C-terminal stability. Community network analysis further show that G127V 
mutation also increase the global correlations of PrP. 
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Results and Discussion 
 
G127V mutation increases the S2-H2 loop rigidity and H2 C-terminal stability 
 
We have performed three individual 2-μs-long simulations for both the globular domain of WT 
PrP (comprising residues 125~228) and its G127V mutant. The initial structure of WT PrP is 
taken from an solution NMR structure,[27] while the G127V mutation is obtained by replacing 
the sidechain of G127 with that of Valine. For each system, we first calculate the time evolution 
of backbone root mean square deviations (RMSDs) with respect to the native WT NMR 
structure. The RMSD values of WT in the three simulations oscillate more largely than those 
of G127V. For example, RMSD values in WT-1 run experience a slow and continuous increase 
from 0.15 nm to 0.40 nm in the first 1.5 μs, followed by a sudden drop after which the RMSD 
values fluctuate around their equilibrium value of ~0.35 nm (Fig. S1a). In contrast, the RMSD 
values in G127V-1 run fluctuates around ~0.25 nm during the full period of the simulation (Fig. 
S1d). The probability density functions (PDF) of the WT and G127V RMSD values in four 
consecutive time windows are shown in Fig. 1b-c. A shift from small RMSD values to larger 
ones can be clearly seen in the PDF of WT RMSD (Fig. 1a), while a similar G127V RMSD 
distribution is observed for all four time windows (a main peak centering 0.24 nm and a satellite 
peak centering 0.33 nm). These results show that the V127 variant has a relatively higher 
structural stability than WT.  
 
We further investigate the influence of G127V mutation on the structural rigidity of PrP by 
calculating the root mean square fluctuation (RMSF) of both WT and G127V systems. As 
shown in Fig. 1d, the RMSF values of almost all residues in G127V is lower than those of WT 
(except for a few residues on the S1-H1 loop). In WT system, the residues in the S2-H2 loop 
(region 1, residues 164~174) and the residues in the C-terminal of H2 and those in H2-H3 loop 
(region 2, residues 192~197) have much higher RMSF values than other non-terminal residues, 
indicating their higher flexibilities than other residues. The high flexibilities of these two 
regions are consistent with previous atomistic and coarse-grained simulation studies on WT 
PrP.[60–64] It is noted that the RMSF values in our work are much higher than those reported in 
the previous all-atom simulation studies, probably due to the much longer simulation time in 
our work than previous studies (2 ns[60], 10 ns[61], 1.8 ns[65], 80 ns[62], 50 ns[63], 100 ns[58,59]). To 
the best of our knowledge, our work is the first microsecond-scale all-atom MD simulation 
study on prion protein. However, the RMSF values of residues in these two regions of the 
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G127V systems are remarkably lower than those of the WT systems. These findings 
demonstrate that the G127V mutation increases the rigidity of the S2-H2 loop, and enhances 
the stability of C-terminal of H2.  
 
 
Figure 1. Stability and rigidity of WT PrP and its V127 variant. (a) A snapshot of the 
human PrP structure. (b-c) PDF of RMSD values in four consecutive time windows of (b) WT 
systems and (c) G127V systems. (d) RMSF of each residue on WT and G127V averaging over 
the three individual simulations for each system. The error bars are calculated by computing 
independent values from each individual simulation and taking the maximums and minimums 
of those values. The two regions where RMSF of G127V is remarkably lower than that of WT 
are labeled “(1)” and “(2)”.  
 
The misfolding of PrP monomer and the consequent oligomerization/fibrilization are closely 
related to the prion disease pathology.[26] The increased rigidity of S2-H2 loop as well as the 
enhanced stability of H2 C-terminal may stabilize the monomeric PrPC structure, thus 
inhibiting the prion conversion of human PrPC to PrPSc and finally preventing prion disease. 
Our interpretation is well supported by the following experimental results. Firstly, the 
relationship between the rigidity of the S2-H2 loop and the PrP’s resistance to prion diseases 
has been extensively discussed in previous studies.[66–69] Accumulating evidence shows that a 
transmission barrier exists between prion proteins carrying rigid S2-H2 loop and those carrying 
flexible one. And mice with a flexible S2-H2 loop is much more easily infected by prions than 
rigid S2-H2 loop mice.[70] Animals (such as bank vole, elk, horse and rabbit) with a rigid S2-
H2 loop PrP usually do not develop prion diseases.[71–75] Secondly, the C-terminal region of 
H2 is identified as the first region to experience conformational conversion of PrPC to PrPSc [76–
78] and the stabilization of PrP H2 may prevent the misfolding and oligomerization of PrP.[79]  
 
 6 
The solution-state NMR structures of bank vole, elk, and horse PrPs have been reported 
(PDBID: 2K56, 1XYW, 2KU4).[71,72,74] Fig. 2a shows the cartoon representations of their S2-
H2 loops (residue 165~174). Surprisingly, they have very similar conformations, comprising a 
helical N-terminal (residue 165-168), and a turn-like region (residue 169-174), as highlighted 
respectively in magenta and blue boxes. The helical nature of residue 165-168 can be further 
characterized by calculating the (Phi, Psi) values of these residues. The (Phi, Psi) values of 
D167 are given in Fig. 2b, and they are distributed around (-80°, -10°), showing a propensity 
towards α-helical structure. Similar results are observed for residue M166 (Fig. S2).  
 
To show whether the S2-H2 loop in V127 variant has a conformation similar to that in bank 
vole, elk, and horse PrPs, we perform cluster analysis on their conformations in the last 1 μs of 
the trajectories using a single-linkage algorithm[80] with an RMSD cutoff of 0.05 nm. As shown 
in Fig. 2c, the S2-H2 loop conformations in WT-1 run are clustered into 270 clusters, 
suggesting a wide variety of loop conformations. We show in Fig. 2f the representative 
configurations of the top four largest clusters. Interestingly, no helical N-terminal region is 
observed in the first and second cluster. Although the third and fourth clusters show a certain 
propensity towards forming helical-like structures, they only comprise respectively 7.6 % and 
7.4 % of all conformations. Analyses of the other two WT systems give similar results (Fig. 
S3). In sharp contrast, for all of the three G127V MD runs, almost all S2-H2 loop 
conformations (containing respectively 97.5%, 99.7%, and 98.7% of conformations in G127V-
1/2/3 system) are clustered into a single cluster, and all of them adopt a conformation similar 
to that of S2-H2 loop in bank vole, elk, and horse PrPs. We show in Fig. 2d-f the representative 
conformations of the S2-H2 loop in the largest cluster with the helical-like N-terminal region 
highlighted in magenta boxes. This propensity towards helical structure is further characterized 
by calculating the potential mean force (PMF) of residue D167 in WT and in G127V PrPs as a 
function of its (Phi, Psi) values. As shown in Fig. 2g, the PMF of WT D167 has three energy 
minimum basins. Two of them are located at (Phi, Psi) values of (-80°, -10°) and (-160°, -10°), 
while the third one is located at a (Phi, Psi) value of (-160°, ±180°). The deepest one at (-80°, 
-10°) corresponds to α-helical structures. In contrast, the D167 PMF of G127V system presents 
only two basins. The α-helical basin of G127V system is deeper and wider than that of WT 
system, suggesting that the S2-H2 loop of G127V system have a higher preference of forming 
helical N-terminal structures than that of WT. These results, together with the fact that prions 
are poorly transmissible to animals with their PrPC carrying a rigid loop, provide explanation 
to the strong resistance of V127 variant against prion diseases. 
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Figure 2. Conformational characteristics of the S2-H2 loop. (a) Snapshots of the S2-H2 
loop (residue 165-174) in three prion-resistant PrPs. The red and blue dashed boxes correspond 
to the two structural characteristics: a helix-like structure and a turn-like loop. (b) The 
Ramachandran plot of residue D167 in bank vole, elk and horse PrPs. (c-f) Snapshots of the 
representative conformations of (c) the top four S2-H2 loop clusters in WT-1 MD run and of 
(c-e) the top one cluster in each G127V MD run. (g-h) PMF of D167 plotted as a function of 
the (Phi, Psi) values in (g) WT and (h) G127V PrPs. 
 
 
G127V mutation enhances local hydrophobic, H-bonding, and salt-bridge interactions in 
the vicinity of S2-H2 loop 
 
Although residues in the S2-H2 loop (residues 164~174) are distant from the mutation site 
(V127) in sequence, they are spatially close to each other (see Fig. 1a). We perform interaction 
analysis to understand how the G127V mutation improves the rigidity of S2-H2 loop. Valine 
has a bulky hydrophobic side chain while Glycine has no side chain, so we suspect that the 
hydrophobic interactions may play an important role. By calculating the contact probability 
between G/V127 and all residues in the S2-H2 loop, we find that the hydrophobic residue P165 
has the highest contact probability with V127 (Fig. S5). The time evolution of P165-G/V127 
contact number in WT-1 and G127V-1 runs show that the P165-G127 contact number 
fluctuates around 2 throughout the full period of simulation, while the P165-V127 contact 
number increases from ~2 to ~6 within the first 0.2 μs and fluctuates around 4 in the remaining 
simulation time (Fig. 3a). Similar result is seen from the other four simulations (WT-2/3, and 
G127V-2,3), and the contact number PDF calculated using a combined trajectory of the three 
individual simulations (Fig. S6b,c, Fig. 3b). These results suggest that the hydrophobic 
interactions between P165 and G/V127 is greatly enhanced as a result of the G127V mutation. 
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Interestingly, a recent work demonstrated that substituting G127 into I127 which possess 
higher hydrophobicity than both Glycine and Valine also significantly decreases the PrP 
cytotoxicity, indicating the important role of the V127-involved hydrophobic interaction in 
preventing prion diseases.[81] 
 
The enhanced V127-P165 hydrophobic interaction may facilitate other residues in PrP 
fragment 125LGVYM129 to interact with the S2-H2 loop (162YYRPMDEY169). We calculate the 
H-bond number between them. As shown in Fig. 3c, the H-bond number in G127V-1 run 
increases with simulation time and reaches ~5, while that in WT-1 run fluctuates around 3. 
Similar results are observed in WT-2/3 and G127V-2/3 systems (Fig. S6e-f), and a statistical 
analysis on all simulations for WT and G127V systems shows that G127V has a higher H-bond 
number than WT (Fig. 3d). A detailed analysis of the H-bonds show that residue E168 plays 
an important role on the H-bond formation: it forms stable H-bonds with three residues (L125, 
G126, and G/V127), and these H-bonds are much more stable in G127V system than in WT 
system (Fig. 3e). In addition, the M129-Y163 H-bond is stable in both WT and G127V system. 
The M129-Y163, and the E165-L125/G126/V127 H-bonds are shown in Fig. 3h-j. The 
enhancement of the E165-involved H-bonds may also contribute to the rigidity of the S2-H2 
loop.  
 
It has been reported that the R164-D178 salt bridge plays an important role on the structural 
stability of PrP.[82,83] To explore the effect of G127V mutation on the stability of this salt bridge, 
we calculate the distance between the charged groups of sidechains in R164 and D178 in WT-
1 and G127V-1 run. Fig. 3f shows that the R164-D178 distance in both systems are close to 
~0.4 nm in most of the simulation time, suggesting the existence of R164-D178 salt bridge in 
both systems. In addition, the distance in WT-1 run has a higher fluctuation than that in G127V-
1. Analyses of the WT-2/3 and G127V-2/3 systems are given in Fig. S6h-I, and a statistical 
analysis using all three simulations is given in Fig. 3g. The PDF curve of R164-D178 distance 
in G127V systems has a single peak centering 0.38 nm, while that in WT systems has a 
dominant peak around 0.38 nm and a satellite peak centered at 0.45 nm. These data indicate 
that the R164-D178 salt bridge in G127V systems is slightly enhanced compared to that in WT. 
 
Taken together, the G127V mutation enhances the V127-P165 hydrophobic interaction, the 
E165-L125/G126/V127 H-bonds, and the R164-D178 salt bridge. These interactions 
collectively rigidify the S2-H2 loop of PrP. 
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Figure 3. Influence of G127V mutation on the interactions in the vicinity of residue 127 
and S2-H2 loop. (a,c,f) Time evolution of (a) contact number between G/V127 and P165, (c) 
number of H-bonds between residues 125~129 and residues 162~169, and (f) centroid distance 
between residue R164 and D178 charged sidechain groups, in WT-1 (blue line) and in G127V-
1 (red line). (b,d,g) Statistical analysis using a combined trajectory of the last 1.0 μs in the three 
simulations of WT and G127V systems. (e) Time evolution of H-bond numbers between 
residues 125~129 and residues 162~169. Only residue pairs forming H-bonds in more than 1/4 
of simulation time are shown. (h-i) Representative snapshots of the N-terminal region and the 
S2-H2 loop region of (h) WT system, and (i) G127V system. (j-k) Snapshots of the G127V 
showing (j) the E168-involved H-bonds, and (k) the R164-D178 salt bridge. 
 
Dynamical network analysis reveals the allosteric paths from the mutation site G/V127 
to the C-terminal of H2 
 
As mentioned above, G127V mutation also enhances the stability of H2 C-terminal region 
(residues 192~197). This region is far from the mutation site (G/V127) both in sequence and 
in space, suggesting that G127V improves the H2 C-terminal stability through an allosteric 
effect. The optimal dynamical path analysis method has been demonstrated as a useful tool for 
identifying allosteric paths in various proteins.[84–88] Here we generate dynamic networks for 
 10 
WT and G127V systems by adding edges between residue pairs with a relatively high contact 
probability (>70%), and constructing the adjacency matrices using the absolute value of the 
inter-residue correlations (Fig. S4). We then calculate the optimal and suboptimal paths 
between residue G/V127 and G195 (the center residue in 192~197 region) to unravel how 
G127V mutation increases the stability of this distant region. 
 
In WT PrP system, we identify two shortest network paths from G127 to G195 (path length = 
317) as well as 15 paths with slightly longer path lengths (between 317 and 327). As shown in 
Table S1, all of these paths are similar: they start from G127, propagate to residue M129 on 
S1, and to V161 on S2, and subsequently to C terminus of H3, then pass to its N-terminal 
through nodes in H3 and finally reach residue G195. We present in Fig. 4a a snapshot showing 
residues located in the shortest path, and in Fig. 4b the correlation values of all edges alongside 
the path. As expected, all edges have high inter-residue correlation values (>0.6), and the edges 
within H3 have the highest correlation values, probably due to the existence of the stable H3 
helix. Most of the edges (especially those located on the helices) connect two residues which 
are close in sequence, expect for the S1-S2 (M129-V161) and the S2-H3 (V161-V210) edges. 
These two edges are stabilized respectively by H-bonds between S1 and S2, and the V161-
V210 hydrophobic interactions. To identify the important residues in this allosteric path, we 
remove the node corresponding to each residue and examine its effect on the optimal path 
length by calculating the path lengths after residue removal. As shown in Fig. 4c, removal of 
residue M129 results in the largest increase of optimal path (14%), revealing its highest 
importance in the G127-G195 allosteric path. In contrast, the optimal allosteric path from V127 
to G195 in G127V system is much shorter than that in WT system (path length = 257). Similar 
to WT system, the V127-G195 allosteric paths start from V127, propagate to residue M129 on 
S1, and to Y162 on S2. However, after that, instead of propagating to C- terminal of H3, the 
allosteric paths propagate to the N-terminal of H2, and pass to its C-terminal through nodes in 
H2 and finally reach residue G195 (Table S2). We show in Fig. 4d all the residues on the 
shortest path, and in Fig. 4e the correlation values of all edges alongside the path in both WT 
and G127V systems. Except for the V127-M129 edge, most edges in G127V system have a 
higher correlation value than those in WT system, suggesting that the correlations in G127V 
system are much stronger than those in WT system. The main difference between the G127V 
allosteric path and the WT path is that S2 connects to H2 in G127V, while it connects to H3 in 
WT. As residues R164 and D178 are located respectively in S2 and H2, the S2-H2 correlation 
in G127V system may result from the enhanced R164-D178 salt bridge. The importance of S2-
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H2 correlation can be revealed by the alternation of optimal path length upon node removal. 
As shown in Fig. 4f, the removal of residue Y162 results in the largest increase in the optimal 
path length (4%). More interestingly, removing the S2-H2 interactions by cutting all edges 
connecting Y162 and H2 (Y162 - C192/I182/T183) leads to a suboptimal V127-G195 path 
(Fig. 4d and Table S3) that is similar to the G127-G195 optimal path in WT system, but with 
a shorter path length (282). These results provide insights into the allosteric effect by which 
G127V mutation enhances stability of the remote region (H2 C-terminal). The optimal 
allosteric path from G127 to H2 C-terminal in WT PrP passes edges connecting S2 and H3. 
After the G127V mutation, the interaction between S2 and H2 N-terminal is enhanced (through 
stabilized R164-D178 salt bridge), thus generates a new optimal allosteric path with a much 
shorter path length. This path passes through edges connecting S2 and H2. In addition, a path 
same to the WT optimal path also exists, but becomes the suboptimal path in G127V. The new-
generated optimal path and the shortened suboptimal path from V127 to the G195 explains the 
increased long-range correlation between the mutation site and the C-terminal of H2, thus 
stabilize the structure of H2 C-terminal. 
 
 
Figure 4. Allosteric paths from the mutation site (G/V127) to the C-terminal of H2 in WT 
and G127V systems.  (a, d) Optimal path from residue G/V127 to G195 in (a) WT PrP and in 
 12 
(d) G127V. (b, e) The correlation values of residue pairs forming the edges along the (b) G127-
G195, and the (e) V127-G195 optimal path. (c, f) Percentage of optimal path length increase 
upon removal of each node of (c) WT and (f) G127V optimal paths.   
 
G127V mutation strengthens the global correlation of the PrP 
 
We further investigate the effect of G127V mutation on the global correlation of PrP by 
calculating the correlation values between each two residues. As shown in Fig. 5a, the WT PrP 
correlation map contains three diagonal positively-correlated regions corresponding to the 
inter-residue interactions in the three helices (red circles), an off-diagonal region corresponding 
to the anti-parallel H2-H3 interaction (blue circle), and two regions corresponding to H2/H3-
S2 interactions (green circles). The G127V correlation map has a similar pattern to WT, but 
the correlation values of the six positively-correlated regions are mostly higher than those of 
WT (Fig. 5b). In addition, more positively-correlated regions are observed in the correlation 
map of G127V system. These results demonstrate that the inter-residue correlations in PrP 
significantly increase after G127V mutation. 
 
Community network method has become a useful strategy for analyzing global correlations for 
biomolecules.[89–93] Based on the dynamical networks of WT and G127V, we calculated the 
optimal community distributions using the Girvan-Newman algorithm.[94] The residues 
belonging to the same community are more strongly and densely interconnected to each other, 
and have weaker connections to other residues in the protein. As shown in Fig. 5c, the WT 
community network comprises ten communities, including a single community for H1, two 
separate communities for N and C terminal of H2 (H2N and H2C), three separate communities 
for N-terminal, middle part, and C-terminal of H3 (H3N, H3M, and H3C), and one single 
community for S2-H2 loop. In sharp contrast, the G127V community network comprises only 
six communities. The three WT communities corresponding to S1/S2, H2N, and H3M have 
combined into one large community, and the two WT communities corresponding to H3N and 
H2C have also combined into one large community. In addition, the inter-community 
connectivity in G127V is stronger than that in WT (the width of edges connecting communities 
corresponds to the inter-community connectivity strength). The decrease in cluster number, the 
combination of several clusters into single large cluster, as well as the increase of inter-
community connectivity strength indicate that the G127V mutation enhances the global 
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correlations and interactions in PrP, thus stabilizes the PrPC structure and inhibits the prion 
conversion to PrPSc. 
 
 
Figure 5. Correlation and community network analysis of WT and V127 variant. (a-b) 
Inter-residue correlation matrices of (a) WT and (b) G127V systems. (c-d) Community 
networks of (c) WT and (d) G127V systems. Left panels: snapshots of the proteins colored by 
communities. Right panels: schematic diagrams of the community networks. Each circle 
represents a single community. The size of the circle and the width of the edges correspond 
respectively to the size of the community and the connectivity strength between two 
communities.  
 
 
Conclusions 
 
We have performed six 2-μs-long MD simulations on the globular domain of WT human PrP 
and its V127 variant to investigate the effect of G127V mutation on the structural and 
dynamical properties of monomeric human PrP, with the aim of understanding the mechanism 
of G127V’s disease-prevention. RMSD and RMSF analyses show that G127V mutation 
increases the structural stability and rigidity of PrP. Especially, (1) the rigidity of the S2-H2 
loop is greatly increased, and (2) the stability of the C-terminal of H2 is enhanced. The increase 
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rigidity and stability of these two regions may inhibit the prion conversion of PrPC into toxic 
PrPSc, thus prevents prion diseases. Our speculation is supported by the fact that prions are 
poorly transmissible to animals with rigid S2-H2 loop and recent findings showing that 
stabilization of H2 of prion protein prevents its misfolding and oligomerization. Interaction 
analysis show that the increased rigidity of the S2-H2 loop results from the enhanced V127-
P165 hydrophobic interaction, E165-L125/G126/V127 H-bonds, and R164-D178 salt bridge. 
The mutation-induced stabilization of the R164-D178 salt-bridge enables the formation of a 
new allosteric path from mutation site to the H2 C-terminal with a much shorter path length 
than the optimal path in WT. The WT optimal path still exists in G127V and becomes the 
suboptimal path. The new optimal path and the shortened suboptimal path lead to an enhanced 
stability of the H2 C-terminal. At last, community network analysis shows that the global 
correlations and interactions in PrP is strengthened by the G127V mutation. Our findings 
provide structural and dynamical basis for understanding the role of human V127 variant in 
preventing prion conversion and propagation, which may be helpful for the rational design of 
potent anti-prion therapies. 
 
Material and Methods 
 
MD simulations 
The initial structure of WT PrP globular domain was taken from a solution NMR structure 
comprising residues 125~228 (PDBID: 1HJM)[27]. We built the G127V structure by replacing 
the sidechain of Glycine with that of Valine using tools implemented in the Pymol package[95]. 
Three individual 2-μs-long MD simulations were performed for each system using the 
AMBER99SB-ILDN force field[96] in combination with the TIP-3P water model. All 
simulations were preformed using the GROMACS-5.1.2 package[97] in the NPT ensemble. 
Electrostatic interactions were treated using the Particle Mesh Ewald (PME) method[98] with a 
real space cut-off of 1.2 nm. The vdW interactions were calculated using a cutoff of 1.2 nm. 
The solute and solvent were separately coupled to an external temperature bath using a velocity 
rescaling method[99] and a pressure bath using the Parrinello-Rahman method[100]. The 
temperature and pressure were maintained at 310 K and 1 bar with a coupling constant of 0.1 
ps, respectively. The neighbor-list was updated every 10 steps with a cut-off distance of 1.2 
nm using a Verlet buffer[101].  
 
Trajectory analysis 
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Trajectory analysis was performed using our in-house-developed codes and the facilities 
implemented in the GROMACS-5.1.2 software package[97]. We discarded the first 1 μs data 
for each MD trajectory to remove the bias of the initial states. Therefore, the structural and 
dynamical properties of each system were based on the simulation data generated in the last 1 
μs. The cluster analysis for the S2-H2 loop was performed using a single linkage method[80] 
with an RMSD cutoff of 0.05 nm. An inter-residue contact was defined when the aliphatic 
carbon atoms of two nonsequential side chains (or main chains) come within 0.54 nm or any 
other atoms of two nonsequential side chains (or main chains) lie within 0.46 nm. One H-bond 
is taken as formed if the N⋯O distance is less than 0.35 nm and the N–H⋯O angle is greater 
than 150°. Graphical analysis and visualizations were performed using the Pymol package[95]. 
 
Generation of weighted dynamical networks 
Dynamical networks of WT and G127V were generated using our in-house-developed codes. 
Each Cα atom was selected as a representative node for the corresponding residue. Edges were 
added between two nodes if the corresponding residues are in contact during a majority of the 
simulation time (>70%). Nearest neighbors in sequence are not considered to be in contact as 
they lead to a number of trivial allosteric paths in the weighted network. The weight of each 
edge was defined as -log|Cij|, where Cij stands for the dynamic cross correlation of two nodes 
(i and j), so that the network distance between two nodes connected by an edge decreases as 
the correlation of two corresponding residues increases.  
 
Optimal and suboptimal allosteric path analysis 
On the basis of the dynamical networks, the allosteric signal transmission from mutation site 
(G/V127) to the C-terminal of H2 (residue 192~197) was analyzed by calculating the allosteric 
paths between residue G/V127 and residue G195. The length of a path Dij between distant 
residues i and j was defined as the sum of the edge weights between the consecutive nodes (k, 
l) along the path: Dij = Σk,lwkl. The path between residue i and j with the shortest distance Dij(0) 
was found by using the Floyd-Warshall algorithm.[102] Because the high correlation values 
between two nodes may not necessarily guarantee strong physical interactions between the 
corresponding residues (it could also result from strong interaction between nearby residue 
pairs), the shortest path as well as the paths whose lengths lie within a certain limit of the 
shortest distance were equally important.[88] We defined the “optimal allosteric path” between 
residue i and j as the shortest paths between residue i and j (path length = Dij(0)) as well as the 
slightly longer paths (path length < Dij(0) + 10). The importance of each residue in the allosteric 
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path was evaluated by calculating the change in optimal path length upon removing the node 
corresponding to this residue while keeping all other contacts in the network intact. Although 
the optimal allosteric path is the most dominant mode of communication between the two 
strongly-correlated remote residues, other paths with longer path length (corresponding to 
weak correlations/interactions) may also play a role. However, the optimal path analysis 
method [88] cannot identify these longer paths. Thus, we identified the most important residue 
in the allosteric effect by the aforementioned residue-removal technique, removed all edges 
connecting to this residue (these edges correspond to the strongest interaction along the optimal 
path), and calculated the path between residue i and j with the shortest distance Dij(1) in this 
modified network. By removing these edges, the network path from the mutation site to its 
strongly-correlated remote residue has to pass through edges corresponding to weak 
interactions. The “suboptimal allosteric path” between residue i and j was thus defined as the 
path with path length Dij(1) as well as the slightly longer paths (path length < Dij(1) + 10). 
Identification of both optimal and suboptimal allosteric paths enables us to reveal the 
mechanism of the mutation-induced enhancement of global structural stability.  
 
Community network analysis 
We calculated the shortest network path between each residue pair (i, j, for i≠j). The 
betweenness of each edge was then defined as the number of shortest paths that cross that edge. 
The optimal community distribution was calculated using the Girvan-Newman algorithm[94], 
which iteratively removed the edge with the highest betweenness and recalculated the 
betweenness of all remaining edges until the modularity of the community network was 
maximized. The modularity is a measure of the quality of a particular division of a network, 
and the bigger the modularity, the better the division quality.[103] The optimal paths and 
dynamical networks were obtained using codes developed by Eargle and Sethi [88] with our 
modifications. Visualization of the community networks was performed using the VMD 
package[104] (snapshots) and the Omni Graffle package (schematic diagrams).  
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Figure S1. Time evolution of RMSD values with respect to the native NMR structure of 
WT PrP in (a-c) three WT systems, and (d-f) three G127V systems. 
 
 
 
Figure S2. The Ramachandran plot of residue M166 in bank vole, elk and horse PrPs. 
 
Figure S3. Cluster analysis of the S2-H2 loop conformations. Snapshots of the 
representative configurations are shown with the numbers under them corresponding to their 
proportions. The backbone RMSD of representative structure of each cluster to the S2-H2 loop 
in three rigid-loop PrPs (bank-vole, elk, and horse PrP) are also shown. 
 
 
 
 
 
 
Figure S4. Adjacency matrices of (a) WT and (b) G127V system. 
 
 
 
 
 
 
Figure S5. Contact probabilities of G/V127 with (1) all residues whose contact 
probability with G/V127 is larger than 0.5, and (2) all residues on the S2-H2 loop.  
 
 
 
 
Figure S6. Influence of G127V mutation on the interactions in the vicinity of residue 127 
and S2-H2 loop. (a, b, c) Time evolution of the contact number between G/V127 and P165. 
(d, e, f) Time evolution of the number of H-bonds between residues 125~129 and residues 
162~169. (g, h, i) Time evolution of the centroid distance between residue R164 and D178 
charged sidechain groups. 
 
  
Table S1. Optimal allosteric path from mutation site (G127) to G195 in WT systems. 
 
Ranking Length HEAD Nodes on the Path END 
   Nodes in S1 Node in S2 (C-terminal)                            Nodes in H3                                (N-terminal) H2-H3 Loop  
1 317 G127 M129  V161     V210  R208   M205 D202 T199 N197 G195 
1 317 G127 M129  V161     V210    M206  D202 T199 N197 G195 
3 321 G127 M129  V161 C214   E211   R208   M205 D202 T199 N197 G195 
4 322 G127 M129 G131 V161     V210  R208   M205 D202 T199 N197 G195 
4 322 G127 M129 G131 V161     V210    M206  D202 T199 N197 G195 
6 323 G127 M129  V161  M213   V210  R208   M205 D202 T199 N197 G195 
6 323 G127 M129  V161  M213    V209    M205 D202 T199 N197 G195 
6 323 G127 M129  V161  M213   V210    M206  D202 T199 N197 G195 
9 325 G127 M129  V161 C214  Q212   V209    M205 D202 T199 N197 G195 
10 326 G127 M129  V161 C214    V210  R208   M205 D202 T199 N197 G195 
10 326 G127 M129 G131 V161 C214   E211   R208   M205 D202 T199 N197 G195 
10 326 G127 M129  V161  M213  E211   R208   M205 D202 T199 N197 G195 
10 326 G127 M129  V161     V210   E207  M205 D202 T199 N197 G195 
10 326 G127 M129  V161 C214    V210    M206  D202 T199 N197 G195 
10 326 G127 M129  V161  M213    V209   M206  D202 T199 N197 G195 
16 327 G127 M129  V161 C214  Q212    R208   M205 D202 T199 N197 G195 
16 327 G127 M129  V161     V210  R208  M206  D202 T199 N197 G195 
 
  
Table S2. Optimal allosteric path from mutation site (V127) to G195 in G127V systems. 
 
Ranking Length HEAD Nodes on the Path END 
    Nodes in S1 Nodes in S2 (N-terminal)                    Nodes in H2                        (C-terminal)  
1 257 V127   M129  Y162  I182  K185  T188  T192  G195 
1 257 V127   M129  Y162 C179 I182  K185  T188  T192  G195 
3 258 V127   M129  Y162  I182  K185   V189  T193 G195 
3 258 V127   M129  Y162 C179 I182  K185   V189  T193 G195 
3 258 V127   M129  Y162     Q186  V189  T193 G195 
3 258 V127   M129  Y162   T183  Q186  V189  T193 G195 
7 260 V127   M129  Y162 C179  T183  Q186  V189  T193 G195 
8 262 V127   M129  Y162  I182   Q186  V189  T193 G195 
8 262 V127   M129  Y162 C179 I182   Q186  V189  T193 G195 
10 263 V127   M129  Y162  I182  K185   V189 T192  G195 
10 263 V127   M129  Y162 C179 I182  K185   V189 T192  G195 
10 263 V127   M129  Y162     Q186  V189 T192  G195 
10 263 V127   M129  Y162   T183  Q186  V189 T192  G195 
14 264 V127   M129  Y162   T183 K185  T188  T192  G195 
15 265 V127 R164 Y128   Y162 C179 I182  K185  T188  T192  G195 
15 265 V127   M129  Y162 C179  T183  Q186  V189 T192  G195 
15 265 V127   M129  Y162   T183 K185   V189  T193 G195 
18 266 V127   M129  Y162 C179  T183 K185  T188  T192  G195 
18 266 V127   M129  Y162     Q186 T188  T192  G195 
18 266 V127   M129  Y162   T183  Q186 T188  T192  G195 
18 266 V127 R164 Y128   Y162 C179 I182  K185   V189  T193 G195 
18 266 V127 R164 Y128   Y162   T183  Q186  V189  T193 G195 
23 267 V127   M129  Y162  I182   Q186  V189 T192  G195 
23 267 V127   M129  Y162 C179 I182   Q186  V189 T192  G195 
23 267 V127   M129  Y162 C179  T183 K185   V189  T193 G195 
 
  
Table S3. Suboptimal allosteric path from mutation site (V127) to G195 in G127V systems. 
 
Ranking Length HEAD Nodes on the Path END 
   S1 S2 (C-terminal)      <------            Nodes in H3              ------>       (N-terminal) H2-H3 Loop  
1 282 V127 M129 V161   V210 E207 K204   T201 T199 N197 G195 
2 284 V127 M129 V161 C214 E211  E207 K204   T201 T199 N197 G195 
3 288 V127 M129 V161 C214  V210 E207 K204   T201 T199 N197 G195 
4 290 V127 M129 V161   V210 E207 K204  D202  T199 N197 G195 
5 292 V127 M129 V161 C214 E211  E207 K204  D202  T199 N197 G195 
5 292 V127 M129 V161   V210 E207  V203   T199 N197 G195 
5 292 V127 M129 V161   V210 E207 K204  D202   N197 G195 
